There may be an increase in vaccine hesitancy but it isn't too late for those who would still want them, one doctor says.

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory virus is spreading quickly.